These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2645646)

  • 1. The change in tumor aggressiveness with age: lessons from experimental animals.
    Kaesberg PR; Ershler WB
    Semin Oncol; 1989 Feb; 16(1):28-33. PubMed ID: 2645646
    [No Abstract]   [Full Text] [Related]  

  • 2. Geriatric correlates of experimental tumor biology.
    Ershler WB
    Oncology (Williston Park); 1992 Feb; 6(2 Suppl):58-61. PubMed ID: 1532738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Routes of body and tumor interaction].
    Pinchuk VG; Balitskiĭ KP
    Vopr Onkol; 1982; 28(5):18-22. PubMed ID: 6124062
    [No Abstract]   [Full Text] [Related]  

  • 4. Aging and cancerigenesis. 3. Effect of age on isoantibody formation.
    Aoki T; Teller MN
    Cancer Res; 1966 Aug; 26(8):1648-52. PubMed ID: 5923163
    [No Abstract]   [Full Text] [Related]  

  • 5. The cellular and molecular basis of the Lyt-1+2- T cell-mediated tumor-eradicating mechanism in vivo.
    Fujiwara H; Hamaoka T
    Bioessays; 1986 Jan; 4(1):19-23. PubMed ID: 3491605
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunity and immunosuppression in tumor growth].
    Govallo VI
    Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
    [No Abstract]   [Full Text] [Related]  

  • 7. Contribution to the understanding of degenerative pathology and a proposal of a global therapeutic solution.
    Willem JP
    Acta Med Hung; 1991; 48(1-2):112-8. PubMed ID: 1813852
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of aging on OX40 agonist-mediated cancer immunotherapy.
    Ruby CE; Weinberg AD
    Cancer Immunol Immunother; 2009 Dec; 58(12):1941-7. PubMed ID: 19288101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological properties of tumor cells that determine the degree of their malignancy].
    Lavrovskiĭ VA; Viksler VKh
    Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antitumor immunity].
    Gordienko SP
    Vopr Onkol; 1987; 33(4):87-91. PubMed ID: 3296436
    [No Abstract]   [Full Text] [Related]  

  • 11. [The time factor in multistage carcinogenesis].
    Anisimov VN
    Vopr Onkol; 1990; 36(7):771-84. PubMed ID: 2205043
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cancer as a specific variant of the evolutionary resistance of adapted cells to damaging factors].
    Monceviciūte-Eringiene E
    Vopr Onkol; 2000; 46(3):255-62. PubMed ID: 10976269
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evidence for a change in tumor aggressiveness with age.
    Holmes FF
    Semin Oncol; 1989 Feb; 16(1):34-40. PubMed ID: 2645648
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activated T-lymphocytes--a mode of physiological tumor defence].
    Röllinghoff M; Wagner H
    Verh Dtsch Ges Inn Med; 1974; 80():1584-6. PubMed ID: 4548989
    [No Abstract]   [Full Text] [Related]  

  • 15. [Parenchymatous-stromal interrelations in tumors and methods for their study].
    Dikshteĭn EA; Vasilenko IV
    Arkh Patol; 1987; 49(6):87-94. PubMed ID: 3310971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimmunomodulation: interventions in aging and cancer. First Stromboli Conference on Aging and Cancer. Stomboli, Sicily, June 7-11, 1987. Proceedings.
    Ann N Y Acad Sci; 1988; 521():1-361. PubMed ID: 3377359
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer, aging and immunotherapy: lessons learned from animal models.
    Lustgarten J
    Cancer Immunol Immunother; 2009 Dec; 58(12):1979-89. PubMed ID: 19238382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunology of malignant neoplasms].
    Ishikawa K
    Nihon Jibiinkoka Gakkai Kaiho; 1982 Jan; 85(1):95-8. PubMed ID: 6979619
    [No Abstract]   [Full Text] [Related]  

  • 19. [A review on mechanism of anti-tumor action of BCG (author's transl)].
    Tokunaga T
    Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
    [No Abstract]   [Full Text] [Related]  

  • 20. [Controversial problems in cancer immunology].
    Vasil'ev NV
    Vopr Onkol; 1988; 34(4):472-6. PubMed ID: 3287764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.